Emit Imaging: Funding, Investors & Team (Oct 2026)
Cryo-Fluorescence Tomography (CFT) is a novel, 3D approach to imaging drug distribution and protein expression in whole animals and large tissue samples. EMIT Imaging offers both instrumentation and services via our imaging platform, XerraTM, a high-resolution, high-sensitivity preclinical imaging tool designed to advance discoveries in biological and drug research. See what you’re missing with standard 2D in vivo fluorescence imaging techniques and utilize CFT to better visualize: - Whole-body drug distribution and delivery - Screening candidate drugs and delivery systems - Whole-body therapeutic protein expression - Multiplexed co-localization of drug with targets - On and off target tissue identification
Emit Imaging has raised $5.3M across 1 funding round on record, the most recent an undisclosed round of $5.3M announced in Oct 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Emit Imaging Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Emit Imaging Funding Rounds
Emit Imaging Founders and Leadership Team
Contact details for the Emit Imaging team: 1 of 1 has an email address on file.
Start 14-day free trial →Emit Imaging Funding Compared to Other Biotechnology Startups
Emit Imaging's latest round of $5.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Emit Imaging in Biotechnology and Baltimore
Companies Similar to Emit Imaging
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Emit Imaging Funding FAQs
What does Emit Imaging do?
Cryo-Fluorescence Tomography (CFT) is a novel, 3D approach to imaging drug distribution and protein expression in whole animals and large tissue samples. EMIT Imaging offers both instrumentation and services via our imaging platform, XerraTM, a high-resolution, high-sensitivity preclinical imaging tool designed to advance discoveries in biological and drug research. See what you’re missing with standard 2D in vivo fluorescence imaging techniques and utilize CFT to better visualize: - Whole-body drug distribution and delivery - Screening candidate drugs and delivery systems - Whole-body therapeutic protein expression - Multiplexed co-localization of drug with targets - On and off target tissue identification
How much funding has Emit Imaging raised?
Emit Imaging has raised $5.3M across 1 round on record. The most recent is an undisclosed round of $5.3M announced in Oct 2024.
When did Emit Imaging last raise funding?
Emit Imaging's most recent funding round on record is an undisclosed round of $5.3M, announced in Oct 2024.
Who founded Emit Imaging?
FundedIQ lists Steven Toddes (Founder) at Emit Imaging.
Where is Emit Imaging headquartered?
Emit Imaging is based in Baltimore, Maryland, United States.
How many employees does Emit Imaging have?
Emit Imaging is in the 11-50 employee band.
How does Emit Imaging's funding compare to other Biotechnology startups?
Emit Imaging's latest round of $5.3M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Emit Imaging Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Emit Imaging is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.